This study focuses on cytokine production by CD4+ T-cells, based on our demonstrations that T-cells, particularly Th1 and Th17 subsets, disproportionately contribute to peripheral inflammation in T2D [19,20]. The gene discussed is CD4; the disease is type 2 diabetes mellitus.